AnalystsInsight

Stephen J McManus (Exane BNP Paribas): Analyst Track Record and Price‑Target Accuracy

Stephen J McManus is one of the top‑ranked analysts in Exent’s 7‑year backtest. What Stephen covers, how Stephen’s ratings lean, how fast price targets were reached and the ratings from before the last 30 days; the full record and the newest calls are members‑only.

Published Updated 2 min readHow we research

Key takeaways

  • Stephen J McManus ranks among the top 50 consumer discretionary analysts in Exent’s ranking, scored on a 7‑year backtest.
  • The exact rank, price‑target hit rate and live calls are members‑only in Exent Gems.
  • Most‑covered stocks: REAL, RVLV, SFIX, CVNA.
  • In the past year Stephen’s ratings were 44% Buy, 33% Hold and 22% Sell.

Stephen J McManus’s track record at a glance

Stephen J McManus of Exane BNP Paribas ranks among the top 50 consumer discretionary analysts in Exent’s ranking, with a focus on consumer discretionary. The top of the ranking is what Exent Gems follows, so Stephen’s exact rank, hit rate and live calls are for members.

MetricStephen J McManusAll analysts
Exent rank—
Price‑target hit rate52.4%
Calls up after 12 months64.0%
Median 12‑month return of calls+13.4%
Median days to hit target91 days
Stocks covered18—

How fast price targets were reached

Time to reach the targetStephen J McManus
Under 30 days54.2%
30–90 days25.0%
90–180 days16.7%
Over 180 days4.2%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Stephen J McManus covers most

REAL · RVLV · SFIX · CVNA · DG · DLTR · RH · SHAK

In the past year Stephen’s ratings were 44% Buy, 33% Hold and 22% Sell.

Stephen J McManus’s latest ratings

DateStockActionRatingPrice target
Mar 30, 2026SHAKInitiated Coverage: BuyBuy$124.00
Mar 30, 2026SHAKInitiated CoverageBuy$124.00
Mar 30, 2026BROSInitiated Coverage: BuyBuy$73.00
Mar 30, 2026BROSInitiated CoverageBuy$73.00
Mar 30, 2026CAVAInitiated CoverageHold$91.00
Mar 30, 2026CAVAInitiated Coverage: HoldHold$91.00
Mar 30, 2026CMGInitiated CoverageHold$37.00
Mar 30, 2026CMGInitiated Coverage: HoldHold$37.00
Mar 30, 2026WINGInitiated Coverage: BuyBuy$275.00
Mar 30, 2026WINGInitiated CoverageBuy$275.00
Mar 30, 2026SGInitiated CoverageSell$4.50
Mar 30, 2026SGInitiated Coverage: SellSell$4.50
  • Mar 30, 2026
    Stock
    SHAK
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $124.00
  • Mar 30, 2026
    Stock
    SHAK
    Action
    Initiated Coverage
    Rating
    Buy
    Price target
    $124.00
  • Mar 30, 2026
    Stock
    BROS
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $73.00
  • Mar 30, 2026
    Stock
    BROS
    Action
    Initiated Coverage
    Rating
    Buy
    Price target
    $73.00
  • Mar 30, 2026
    Stock
    CAVA
    Action
    Initiated Coverage
    Rating
    Hold
    Price target
    $91.00
  • Mar 30, 2026
    Stock
    CAVA
    Action
    Initiated Coverage: Hold
    Rating
    Hold
    Price target
    $91.00
  • Mar 30, 2026
    Stock
    CMG
    Action
    Initiated Coverage
    Rating
    Hold
    Price target
    $37.00
  • Mar 30, 2026
    Stock
    CMG
    Action
    Initiated Coverage: Hold
    Rating
    Hold
    Price target
    $37.00
  • Mar 30, 2026
    Stock
    WING
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $275.00
  • Mar 30, 2026
    Stock
    WING
    Action
    Initiated Coverage
    Rating
    Buy
    Price target
    $275.00
  • Mar 30, 2026
    Stock
    SG
    Action
    Initiated Coverage
    Rating
    Sell
    Price target
    $4.50
  • Mar 30, 2026
    Stock
    SG
    Action
    Initiated Coverage: Sell
    Rating
    Sell
    Price target
    $4.50

Ratings from the last 30 days are members‑only in Exent Gems, with the stocks where several top‑ranked analysts agree; older ratings are shown in full.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Stephen J McManus’s full record and latest ratings, without the 30‑day delay.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring, Stephen J McManus ranks among the top 50 consumer discretionary analysts in Exent’s ranking, based on a 7-year backtest of price-target hit rate, returns after calls and number of ratings. The exact rank, hit rate and live calls are members-only in Exent Gems (exent.ai/radar). Past accuracy does not guarantee future accuracy.

Stephen J McManus’s price-target hit rate is part of the members-only record in Exent Gems (exent.ai/radar). For comparison, the average analyst’s price targets were reached 52.4% of the time.

Stephen J McManus (Exane BNP Paribas) covers 18 stocks, mostly in consumer discretionary. The most frequently rated are REAL, RVLV, SFIX, CVNA, DG.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.